Home › Research › How common it is
Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study
David Bachman, Philip A. Wolf, Richard T. Linn, Janice E. Knoefel, J. L. Cobb, Albert J. Belanger, L. R. B. White, Ralph B. D’Agostino. Neurology, 1993-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
OBJECTIVE: To determine the incidence of dementia and Alzheimer's disease (AD) in a general population sample. BACKGROUND: Utilizing subjects in the Framingham Study cohort determined to be free of dementia in 1976 to 1978, or on biennial examination 17 in 1982, all new cases of dementia arising in this cohort over a maximum of 10 years of follow-up were ascertained. METHODS: On biennial examination 14/15, a screening neuropsychologic examination was administered to 2,117 subjects, and cases of probable prevalent dementia were identified. Beginning on examination 17 and on all successive biennial examinations, a Mini-Mental State Examination was administered. Subjects previously free of dementia and falling below age-education levels were evaluated by a neurologist and neuropsychologist to determine if dementia was present and to ascertain the dementia type using standard criteria. RESULTS: Five-year incidence of dementia increased with age, doubling in successive 5-year age groups. Dementia incidence rose from 7.0 per 1,000 at ages 65 to 69 to 118.0 per 1,000 at ages 85 to 89 for men and women combined. Incidence of probable AD also doubled with successive quinquennia from 3.5 at ages 65 to 69 to 72.8 per 1,000 at ages 85 to 89 years. Incidence of dementia and of probable AD did not level off with age and was not different in men and women. CONCLUSIONS: In a general population sample, we determined incidence of dementia and of probable AD and will use these incident cases for study of precursors and natural history in this elderly cohort, which has been under close surveillance for over 40 years.
What this study adds
Evidence grade: Not rated
In the Framingham Study cohort followed for up to 10 years, dementia incidence doubled in each successive 5-year age group, from 7.0 per 1,000 at ages 65 to 69 to 118.0 per 1,000 at ages 85 to 89. Incidence of probable Alzheimer's disease also doubled with age, and neither rate leveled off with age or differed between men and women.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bachman, D., Wolf, P. A., Linn, R. T., Knoefel, J. E., Cobb, J. L., Belanger, A. J., et al. (1993). Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. https://doi.org/10.1212/wnl.43.3_part_1.515
Vancouver
Bachman D, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993. doi:10.1212/wnl.43.3_part_1.515. PMID: 8450993.
BibTeX
@article{bachman1993-8450993,
author = {Bachman, David and Wolf, Philip A. and Linn, Richard T. and Knoefel, Janice E. and Cobb, J. L. and Belanger, Albert J. and White, L. R. B. and D’Agostino, Ralph B.},
title = {{Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study}},
journal = {Neurology},
year = {1993},
doi = {10.1212/wnl.43.3_part_1.515},
pmid = {8450993},
url = {https://doi.org/10.1212/wnl.43.3_part_1.515}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Why it matters
In the Framingham Study cohort followed for up to 10 years, dementia incidence doubled in each successive 5-year age group, from 7.0 per 1,000 at ages 65 to 69 to 118.0 per 1,000 at ages 85 to 89. Incidence of probable Alzheimer's disease also doubled with age, and neither rate leveled off with age or differed between men and women.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
How this study scored 52/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on strength of evidence, so that was left out: it earned 49 of the 95 points we could judge it on, which is 52 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1993 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 472 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 13.5 citations a year over 35 year(s) since 1993 |
| Impact for its field and year | 4 / 6 | Cited 10.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 13 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Ralph B. D’Agostino: h-index 237 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | National Institutes of Health: institution h-index 2,723 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8450993) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 49 / 95 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 49 of the 95 points we could judge it on is 52 out of 100. |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in How common it is from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.